---
status: 
tags: 
type: 
aliases: VWF, vWF
publish: true
---

Von Willebrand Factor (VWF) is a large multimeric glycoprotein that plays a critical role in hemostasis, the process by which blood clots to prevent bleeding after injury.

The role of VWF in hemostasis involves several important functions:

1.  Platelet adhesion: VWF acts as a bridge between platelets and damaged blood vessels, promoting platelet adhesion to the site of injury.
    
2.  Platelet aggregation: VWF also promotes the formation of platelet aggregates by binding to platelet receptors, such as glycoprotein Ib (GPIb).
    
3.  Stabilization of Factor VIII: VWF also serves as a carrier protein for Factor VIII, a key clotting factor that is essential for the coagulation cascade. VWF stabilizes Factor VIII in circulation and protects it from rapid clearance.
    

Deficiency or dysfunction of VWF can lead to bleeding disorders such as von Willebrand disease (VWD), which is the most common inherited bleeding disorder, characterized by impaired platelet adhesion and decreased levels of Factor VIII.

Overall, vWF plays a critical role in the initial stages of hemostasis, promoting platelet adhesion and activation, and protecting and delivering FVIII. Deficiencies or abnormalities in vWF can lead to bleeding disorders such as von Willebrand disease, where the blood cannot clot properly.

![](https://i.imgur.com/JYpsd7J.png)

![](https://i.imgur.com/BsRKZzP.png)
